147 related articles for article (PubMed ID: 19189271)
1. Antiestrogenic and anticancer activities of peptides derived from the active site of alpha-fetoprotein.
Joseph LC; Bennett JA; Kirschner KN; Shields GC; Hughes J; Lostritto N; Jacobson HI; Andersen TT
J Pept Sci; 2009 Apr; 15(4):319-25. PubMed ID: 19189271
[TBL] [Abstract][Full Text] [Related]
2. AFPep: an anti-breast cancer peptide that is orally active.
Bennett JA; DeFreest L; Anaka I; Saadati H; Balulad S; Jacobson HI; Andersen TT
Breast Cancer Res Treat; 2006 Jul; 98(2):133-41. PubMed ID: 16538538
[TBL] [Abstract][Full Text] [Related]
3. Anticancer versus antigrowth activities of three analogs of the growth-inhibitory peptide: relevance to physicochemical properties.
Mizejewski GJ; Eisele L; Maccoll R
Anticancer Res; 2006; 26(4B):3071-6. PubMed ID: 16886636
[TBL] [Abstract][Full Text] [Related]
4. Prevention of N-methyl-N-nitrosourea-induced breast cancer by alpha-fetoprotein (AFP)-derived peptide, a peptide derived from the active site of AFP.
Parikh RR; Gildener-Leapman N; Narendran A; Lin HY; Lemanski N; Bennett JA; Jacobson HI; Andersen TT
Clin Cancer Res; 2005 Dec; 11(23):8512-20. PubMed ID: 16322315
[TBL] [Abstract][Full Text] [Related]
5. Anti-prostate cancer and anti-breast cancer activities of two peptides derived from alpha-fetoprotein.
Caceres G; Dauphinee MJ; Eisele LE; MacColl R; Mizejewski GJ
Anticancer Res; 2002; 22(5):2817-20. PubMed ID: 12530002
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of biologically active peptides: a 'tail' of amino acids can modulate activity of synthetic cyclic peptides.
Bryan A; Joseph L; Bennett JA; Jacobson HI; Andersen TT
Peptides; 2011 Dec; 32(12):2504-10. PubMed ID: 22015269
[TBL] [Abstract][Full Text] [Related]
7. Synthetic peptide derived from alpha-fetoprotein inhibits growth of human breast cancer: investigation of the pharmacophore and synthesis optimization.
DeFreest LA; Mesfin FB; Joseph L; McLeod DJ; Stallmer A; Reddy S; Balulad SS; Jacobson HI; Andersen TT; Bennett JA
J Pept Res; 2004 May; 63(5):409-19. PubMed ID: 15140158
[TBL] [Abstract][Full Text] [Related]
8. Alpha-fetoprotein derived from a human hepatoma prevents growth of estrogen-dependent human breast cancer xenografts.
Bennett JA; Zhu S; Pagano-Mirarchi A; Kellom TA; Jacobson HI
Clin Cancer Res; 1998 Nov; 4(11):2877-84. PubMed ID: 9829755
[TBL] [Abstract][Full Text] [Related]
9. A peptide derived from alpha-fetoprotein inhibits the proliferation induced by estradiol in mammary tumor cells in culture.
Sierralta WD; Epuñan MJ; Reyes JM; Valladares LE; Andersen TT; Bennett JA; Jacobson HI; Pino AM
Oncol Rep; 2008 Jan; 19(1):229-35. PubMed ID: 18097600
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of AFPep, a cyclic peptide with anti-breast cancer properties.
Mansouri W; Fordyce SB; Wu M; Jones D; Cohn D; Lin Q; Feustel P; Sharma T; Bennett JA; Andersen TT
Toxicol Appl Pharmacol; 2018 Apr; 345():10-18. PubMed ID: 29518411
[TBL] [Abstract][Full Text] [Related]
11. Antiestrogenic glyceollins suppress human breast and ovarian carcinoma tumorigenesis.
Salvo VA; Boué SM; Fonseca JP; Elliott S; Corbitt C; Collins-Burow BM; Curiel TJ; Srivastav SK; Shih BY; Carter-Wientjes C; Wood CE; Erhardt PW; Beckman BS; McLachlan JA; Cleveland TE; Burow ME
Clin Cancer Res; 2006 Dec; 12(23):7159-64. PubMed ID: 17145841
[TBL] [Abstract][Full Text] [Related]
12. Review and proposed action of alpha-fetoprotein growth inhibitory peptides as estrogen and cytoskeleton-associated factors.
Mizejewski G; Smith G; Butterstein G
Cell Biol Int; 2004; 28(12):913-33. PubMed ID: 15566961
[TBL] [Abstract][Full Text] [Related]
13. Alpha-fetoprotein-derived antiestrotrophic octapeptide.
Mesfin FB; Bennett JA; Jacobson HI; Zhu S; Andersen TT
Biochim Biophys Acta; 2000 Apr; 1501(1):33-43. PubMed ID: 10727847
[TBL] [Abstract][Full Text] [Related]
14. Update of alpha fetoprotein growth-inhibitory peptides as biotherapeutic agents for tumor growth and metastasis.
Mizejewski GJ; Muehlemann M; Dauphinee M
Chemotherapy; 2006; 52(2):83-90. PubMed ID: 16498241
[TBL] [Abstract][Full Text] [Related]
15. Computational design and experimental discovery of an antiestrogenic peptide derived from alpha-fetoprotein.
Kirschner KN; Lexa KW; Salisburg AM; Alser KA; Joseph L; Andersen TT; Bennett JA; Jacobson HI; Shields GC
J Am Chem Soc; 2007 May; 129(19):6263-8. PubMed ID: 17441722
[TBL] [Abstract][Full Text] [Related]
16. Substance P analogs containing alpha,alpha-dialkylated amino acids with potent anticancer activity.
Prasad S; Mathur A; Jaggi M; Singh AT; Mukherjee R
J Pept Sci; 2007 Aug; 13(8):544-8. PubMed ID: 17617800
[TBL] [Abstract][Full Text] [Related]
17. Development of an active site peptide analog of α-fetoprotein that prevents breast cancer.
Jacobson HI; Andersen TT; Bennett JA
Cancer Prev Res (Phila); 2014 Jun; 7(6):565-73. PubMed ID: 24706695
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of doxorubicin-formaldehyde conjugates targeted to breast cancer cells.
Burke PJ; Koch TH
J Med Chem; 2004 Feb; 47(5):1193-206. PubMed ID: 14971899
[TBL] [Abstract][Full Text] [Related]
19. Targeted delivery of anti-cancer growth inhibitory peptides derived from human alpha-fetoprotein: review of an International Multi-Center Collaborative Study.
Mizejewski GJ; Mirowski M; Garnuszek P; Maurin M; Cohen BD; Poiesz BJ; Posypanova GA; Makarov VA; Severin ES; Severin SE
J Drug Target; 2010 Sep; 18(8):575-88. PubMed ID: 20151941
[TBL] [Abstract][Full Text] [Related]
20. AFPep, a novel drug for the prevention and treatment of breast cancer, does not disrupt the estrous cycle or fertility in rats.
Tower AM; Trinward A; Lee K; Joseph L; Jacobson HI; Bennett JA; Andersen TT
Oncol Rep; 2009 Jul; 22(1):49-56. PubMed ID: 19513504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
